Sibold William John 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Mar 7, 2025
Insider Transaction Report
Form 4
Sibold William John
DirectorPresident and CEO
Transactions
- Award
Common Stock
2025-03-05+13,066→ 117,369 total - Award
Stock Option (Right to Buy)
2025-03-05+22,009→ 22,009 totalExercise: $347.28Exp: 2035-03-05→ Common Stock (22,009 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 5, 2026, March 5, 2027, March 5, 2028 and March 5, 2029, provided the Reporting Person continues in service with the Issuer on each such date.
- [F2]The option vests as to 25% of the shares on the first anniversary of the date of grant (March 5, 2026) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.